Fungal Metabolites as Pharmaceuticals

Andrew M. Beekman, Russell A. Barrow

Research output: Contribution to journalArticlepeer-review

26 Citations (Scopus)

Abstract

Natural products, their derivatives or compounds based on natural product leads constitute ~50 % of clinically used pharmaceuticals. This review highlights pharmaceuticals currently used in Australia and New Zealand that have their origins in fungal metabolites, discussing the natural products chemistry and medicinal chemistry leading to their application as pharmaceuticals.
Original languageEnglish
Pages (from-to)827-843
JournalAustralian Journal of Chemistry
Volume67
Issue number6
DOIs
Publication statusPublished - 19 May 2014

Cite this